Posted in | News | Business | Aluminum / Aluminium

Alouette Aluminium Plant to Undergo Expansion

Oct 2 2002

Related Stories

The Alouette primary aluminium plant in Canada will be undergoing an expansion project following approval from shareholders. The total investment in the plant will CAD 1.41 billion and the project will begin in February 2005.

Following the expansion, the plant will have a capacity of 550,000 tonnes per year, which represents an increase of 307,000 tonnes. It will also be amongst the lowest cost primary aluminium plants in the world. With operating costs of less then US$1000 per tonne, it will rank among the top 10% of low cost smelters worldwide.

The Alouette plant is a joint venture, of which 20% is owned by Hydro Aluminium. They acquired the share through the acquisition of the German company VAW.

For more information on aluminium, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback